These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24482737)

  • 1. Mutation of the retinoblastoma tumor suppressor gene sensitizes cancers to mitotic inhibitor induced cell death.
    Zhao J; Zhang Z; Liao Y; Du W
    Am J Cancer Res; 2014; 4(1):42-52. PubMed ID: 24482737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death.
    Danos AM; Liao Y; Li X; Du W
    Cancer Lett; 2013 Jan; 328(1):36-43. PubMed ID: 23022476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.
    Hernando E; Nahlé Z; Juan G; Diaz-Rodriguez E; Alaminos M; Hemann M; Michel L; Mittal V; Gerald W; Benezra R; Lowe SW; Cordon-Cardo C
    Nature; 2004 Aug; 430(7001):797-802. PubMed ID: 15306814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: Retinoblastoma protein inactivation mediates effects of histone deacetylase inhibitor-induced Wnt hyperactivation in colorectal cancer cells.
    Bordonaro M
    J Cancer; 2020; 11(3):668-677. PubMed ID: 31942190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
    Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
    Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rb pathway and cancer therapeutics.
    Du W; Searle JS
    Curr Drug Targets; 2009 Jul; 10(7):581-9. PubMed ID: 19601762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific lytic path "hyperploid progression mediated death": Resolving side effects through targeting retinoblastoma or p53 mutant.
    Hong FU; Castro M; Linse K
    World J Clin Oncol; 2020 Nov; 11(11):854-867. PubMed ID: 33312882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.
    Bosco EE; Wang Y; Xu H; Zilfou JT; Knudsen KE; Aronow BJ; Lowe SW; Knudsen ES
    J Clin Invest; 2007 Jan; 117(1):218-28. PubMed ID: 17160137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma tumor suppressor and genome stability.
    Zheng L; Lee WH
    Adv Cancer Res; 2002; 85():13-50. PubMed ID: 12374284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-linked kinase regulates senescence in an Rb-dependent manner in cancer cell lines.
    Duminuco R; Noble JW; Goody J; Sharma M; Ksander BR; Roskelley CD; Cox ME; Mills J
    Cell Cycle; 2015; 14(18):2924-37. PubMed ID: 26176204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of RB status on E2F1 reprogramming in human cancer.
    McNair C; Xu K; Mandigo AC; Benelli M; Leiby B; Rodrigues D; Lindberg J; Gronberg H; Crespo M; De Laere B; Dirix L; Visakorpi T; Li F; Feng FY; de Bono J; Demichelis F; Rubin MA; Brown M; Knudsen KE
    J Clin Invest; 2018 Jan; 128(1):341-358. PubMed ID: 29202480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.
    Landreville S; Ma D; Wu J; Harbour JW
    Curr Eye Res; 2010 May; 35(5):435-9. PubMed ID: 20450257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death.
    Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES
    Oncogene; 1999 Sep; 18(37):5239-45. PubMed ID: 10498874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the retinoblastoma susceptibility gene.
    Goodrich DW; Lee WH
    Biochim Biophys Acta; 1993 May; 1155(1):43-61. PubMed ID: 8504130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Rb inactivation in cancers by synthetic lethality.
    Gordon GM; Du W
    Am J Cancer Res; 2011 Jun; 1(6):773-86. PubMed ID: 21814623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells.
    Radisavljevic Z
    J Cell Biochem; 2004 May; 92(1):1-5. PubMed ID: 15095398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular cancer epidemiology--the present status and future possibilities].
    Sakai T
    Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1036-46. PubMed ID: 8720930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation.
    Kitajima S; Takahashi C
    Cancer Sci; 2017 Sep; 108(9):1726-1731. PubMed ID: 28865172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.